Contact
Please use this form to send email to PR contact of this press release:
Immunomedics Announces Oral Presentation of Sacituzumab Govitecan in Metastatic Urothelial Cancer at ESMO 2019 Annual Congress
TO:
Please use this form to send email to PR contact of this press release:
Immunomedics Announces Oral Presentation of Sacituzumab Govitecan in Metastatic Urothelial Cancer at ESMO 2019 Annual Congress
TO: